Takeda Pharmaceutical
TAK
#332
Rank
A$105.08 B
Marketcap
A$32.89
Share price
1.68%
Change (1 day)
50.55%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): A$0.82 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.55 Billion. In 2025 the company made an earning of A$5.02 Billion, an increase over its 2024 earnings that were of A$3.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.82 B-83.67%
2025 A$5.02 B49.03%
2024 A$3.37 B-2.41%
2023 A$3.45 B-28.14%
2022 A$4.80 B-40.9%
2021 A$8.13 B78.24%
2020 A$4.56 B246.1%
2019 A$1.31 B-48.79%
2018 A$2.57 B-23.64%
2017 A$3.37 B21.7%
2016 A$2.77 B-253.01%
2015 -A$1.82 Billion-159.65%
2014 A$3.03 B13%
2013 A$2.68 B2.46%
2012 A$2.62 B-57.05%
2011 A$6.10 B-10.49%
2010 A$6.81 B-3.99%
2009 A$7.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$19.10 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.52 B 1,248.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.69 B 2,039.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.76 B 1,407.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.15 B 1,201.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.80 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.2 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$0.64 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India